424 related articles for article (PubMed ID: 17673563)
21. [Mitochondria permeability transition as a target for ischemic preconditioning].
Hoshovs'ka IuV; Shymans'ka TV; Rudyk OV; Korkach IuP; Sahach VF
Fiziol Zh (1994); 2011; 57(4):34-45. PubMed ID: 22164407
[TBL] [Abstract][Full Text] [Related]
22. Postconditioning with glucagon like peptide-2 reduces ischemia/reperfusion injury in isolated rat hearts: role of survival kinases and mitochondrial KATP channels.
Penna C; Pasqua T; Perrelli MG; Pagliaro P; Cerra MC; Angelone T
Basic Res Cardiol; 2012 Jul; 107(4):272. PubMed ID: 22699364
[TBL] [Abstract][Full Text] [Related]
23. In vivo hyperoxic preconditioning protects against rat-heart ischemia/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release.
Petrosillo G; Di Venosa N; Moro N; Colantuono G; Paradies V; Tiravanti E; Federici A; Ruggiero FM; Paradies G
Free Radic Biol Med; 2011 Feb; 50(3):477-83. PubMed ID: 21130864
[TBL] [Abstract][Full Text] [Related]
24. Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway.
Song T; Lv LY; Xu J; Tian ZY; Cui WY; Wang QS; Qu G; Shi XM
Exp Biol Med (Maywood); 2011 Dec; 236(12):1427-36. PubMed ID: 22075552
[TBL] [Abstract][Full Text] [Related]
25. Mitochondria in postconditioning.
Boengler K; Heusch G; Schulz R
Antioxid Redox Signal; 2011 Mar; 14(5):863-80. PubMed ID: 20578961
[TBL] [Abstract][Full Text] [Related]
26. Signalling pathways in ischaemic postconditioning.
Hausenloy DJ
Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
[TBL] [Abstract][Full Text] [Related]
27. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
28. Cardioprotection: a radical view Free radicals in pre and postconditioning.
Penna C; Mancardi D; Rastaldo R; Pagliaro P
Biochim Biophys Acta; 2009 Jul; 1787(7):781-93. PubMed ID: 19248760
[TBL] [Abstract][Full Text] [Related]
29. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
[TBL] [Abstract][Full Text] [Related]
30. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.
Vinten-Johansen J; Shi W
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):260-6. PubMed ID: 21821526
[TBL] [Abstract][Full Text] [Related]
31. The RISK pathway leading to mitochondria and cardioprotection: how everything started.
Yellon DM; Beikoghli Kalkhoran S; Davidson SM
Basic Res Cardiol; 2023 May; 118(1):22. PubMed ID: 37233787
[TBL] [Abstract][Full Text] [Related]
32. STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart.
Oshima Y; Fujio Y; Nakanishi T; Itoh N; Yamamoto Y; Negoro S; Tanaka K; Kishimoto T; Kawase I; Azuma J
Cardiovasc Res; 2005 Feb; 65(2):428-35. PubMed ID: 15639482
[TBL] [Abstract][Full Text] [Related]
33. Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.
Chung YW; Lagranha C; Chen Y; Sun J; Tong G; Hockman SC; Ahmad F; Esfahani SG; Bae DH; Polidovitch N; Wu J; Rhee DK; Lee BS; Gucek M; Daniels MP; Brantner CA; Backx PH; Murphy E; Manganiello VC
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2253-62. PubMed ID: 25877153
[TBL] [Abstract][Full Text] [Related]
34. Postconditioning: reduction of reperfusion-induced injury.
Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 2006 May; 70(2):200-11. PubMed ID: 16545349
[TBL] [Abstract][Full Text] [Related]
35. Persistent inhibition of mitochondrial permeability transition by preconditioning during the first hours of reperfusion.
Argaud L; Loufouat J; Gateau-Roesch O; Gomez L; Robert D; Ovize M
Shock; 2008 Nov; 30(5):552-6. PubMed ID: 18317409
[TBL] [Abstract][Full Text] [Related]
36. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.
Simpkin JC; Yellon DM; Davidson SM; Lim SY; Wynne AM; Smith CC
Basic Res Cardiol; 2007 Nov; 102(6):518-28. PubMed ID: 17694254
[TBL] [Abstract][Full Text] [Related]
37. Cardioprotection against myocardial reperfusion injury: successes, failures, and perspectives.
Duicu OM; Angoulvant D; Muntean DM
Can J Physiol Pharmacol; 2013 Aug; 91(8):657-62. PubMed ID: 23889135
[TBL] [Abstract][Full Text] [Related]
38. Preconditioning the hyperlipidemic myocardium: fact or fantasy?
Balakumar P; Babbar L
Cell Signal; 2012 Mar; 24(3):589-95. PubMed ID: 22101013
[TBL] [Abstract][Full Text] [Related]
39. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
Hausenloy DJ; Yellon DM
Heart Fail Rev; 2007 Dec; 12(3-4):217-34. PubMed ID: 17541822
[TBL] [Abstract][Full Text] [Related]
40. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition.
Hönisch A; Theuring N; Ebner B; Wagner C; Strasser RH; Weinbrenner C
Basic Res Cardiol; 2010 Mar; 105(2):155-67. PubMed ID: 19842009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
